Paolo Grazioli

Dr. Paolo Grazioli

University of Milan, Milan, Lombardy, Italy
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2022 in Genes
Verified
Journal Article
Open access
PDF file
SCSilvia Castiglioni
Silvia Castiglioni
EFElisabetta Di Fede
Elisabetta Di Fede
CBClara Bernardelli
Clara Bernardelli
ALAntonella Lettieri
Antonella Lettieri
CPChiara Parodi
Chiara Parodi
CGCristina Gervasini
Cristina Gervasini
KMT2A (Lysine methyltransferase 2A) is a member of the epigenetic machinery, encoding a lysine methyltransferase responsible for the transcriptional activation through lysine 4 of histone 3 (H3K4) methylation. KMT2A has a crucial role in gene expression, thus it is associated to pathological conditions when found mutated. KMT2A germinal mutations are associated to Wiedemann–Steiner syndrome and also in patients with initial clinical diagnosis of several other chromatinopathies (i.e., Coffin–Siris syndromes, Kabuki syndrome, Cornelia De Lange syndrome, Rubinstein–Taybi syndrome), sharing an overlapping phenotype. On the other hand, KMT2A somatic mutations have been reported in several tumors, mainly blood malignancies. Due to its evolutionary conservation, the role of KMT2A in embryonic development, hematopoiesis and neurodevelopment has been explored in different animal models, and in recent decades, epigenetic treatments for disorders linked to KMT2A dysfunction have been extensively investigated. To note, pharmaceutical compounds acting on tumors characterized by KMT2A mutations have been formulated, and even nutritional interventions for chromatinopathies have become the object of study due to the role of microbiota in epigenetic regulation.

13 November 2019 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
LALaura Avagliano
Laura Avagliano
IPIlaria Parenti
Ilaria Parenti
Paolo GrazioliPaolo Grazioli
Paolo Grazioli
EFElisabetta Di Fede
Elisabetta Di Fede
CPChiara Parodi
Chiara Parodi
VALENTINA MASsAVALENTINA MASsA
VALENTINA MASsA

18 July 2019 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
NLNoelia Luna-Peláez
Noelia Luna-Peláez
RMRosana March-Díaz
Rosana March-Díaz
MCMaría Ceballos-Chávez
María Ceballos-Chávez
JGJose A. Guerrero-Martínez
Jose A. Guerrero-Martínez
Paolo GrazioliPaolo Grazioli
Paolo Grazioli
MGMario García-Domínguez
Mario García-Domínguez
Mutations in NIPBL are the major cause of Cornelia de Lange Syndrome (CdLS). NIPBL is the cohesin-loading factor and has recently been associated with the BET (bromodomains and extra-terminal (ET) domain) proteins BRD2 and BRD4. Related to this, a CdLS-like phenotype has been described associated to BRD4 mutations. Here, we show direct interaction of NIPBL with different BET members in yeast, and selective interaction with BRD4 in cells, being the ET domain involved in the interaction. To understand the relationship between NIPBL and BET proteins, we have performed RNA-Seq expression analysis following depletion of the different proteins. Results indicate that genes regulated by NIPBL largely overlap with those regulated by BRD4 but not with those regulated by BRD2. ChIP-Seq analysis indicates preferential NIPBL occupancy at promoters, and knockdown experiments show mutual stabilization of NIPBL and BRD4 on co-regulated promoters. Moreover, human fibroblasts from CdLS probands with mutations in NIPBL show reduced BRD4 at co-occupied promoters. Functional analysis in vivo, using mutants of Drosophila melanogaster, confirmed the genetic interaction between Nipped-B and fs(1)h, the orthologs of human NIPBL and BRD4, respectively. Thus, we provide evidence for NIPBL and BRD4 cooperation in transcriptional regulation, which should contribute to explain the recently observed CdLS-like phenotype associated with BRD4 mutations.

14 September 2018 in Human Molecular Genetics
Verified
Journal Article
Closed access
PDF file
Daniele BottaiDaniele Bottai
Daniele Bottai
MSMarco Spreafico
Marco Spreafico
APAnna Silvia Pistocchi
Anna Silvia Pistocchi
GFGrazia Fazio
Grazia Fazio
RARaffaella Adami
Raffaella Adami
VALENTINA MASsAVALENTINA MASsA
VALENTINA MASsA
Cornelia de Lange Syndrome (CdLS), which is reported to affect about 1 in 10,000 to 30,000 newborns, is a multisystem organ developmental disorder with relatively mild to severe effects. Among others, intellectual disability represents an important feature of this condition. Cornelia de Lange syndrome can result from mutations in at least five genes: NIPBL (nipped-B-like protein), SMC1A (structural maintenance of chromosomes 1A), SMC3 (structural maintenance of chromosomes 3), RAD21 (RAD21 Cohesin Complex Component), and HDAC8 (Histone deacetylase 8). It is believed that mutations in these genes cause CdLS by impairing the function of the cohesin complex (to which all the aforementioned genes contribute to the structure or function), disrupting gene regulation during critical stages of early development. Since intellectual disorder might result from alterations in neural development, in this work, we studied the role of Hdac8 gene in mouse neural stem cells and in vertebrate (D.rerio) brain development by knock-down and chemical inhibition experiments. An underlying features of Hdac8 deficiency is an increased cell death in the developing neural tissues, either in mouse NSCs and in zebrafish embryos.

21 November 2017 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
LALaura Avagliano
Laura Avagliano
Paolo GrazioliPaolo Grazioli
Paolo Grazioli
MMMilena Mariani
Milena Mariani
GBGaetano P. Bulfamante
Gaetano P. Bulfamante
ASAngelo Selicorni
Angelo Selicorni
VALENTINA MASsAVALENTINA MASsA
VALENTINA MASsA
Cornelia de Lange Syndrome (CdLS) is a choesinopathy: a severe genetic disorder caused by mutations in the cohesin complex genes. The phenotype is characterized by typical facial dysmorphism, growth impairment and multiorgan abnormalities including brain alterations. Wnt pathway is known to play a fundamental role in central nervous system development and it has been shown that Wnt pathway is disrupted in CdLS animal models and patients cells. In this review we investigate the possible link between Wnt pathway disruption and brain abnormalities in Cornelia de Lange Syndrome as such molecular impairment could lead to an abnormal embryonic development resulting in brain abnormalities (i.e. microcephaly, cerebellar hypoplasia, abnormal cortical development) in patients with Cornelia de Lange Syndrome.

17 February 2021 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
Paolo GrazioliPaolo Grazioli
Paolo Grazioli
CPChiara Parodi
Chiara Parodi
MMMilena Mariani
Milena Mariani
Daniele BottaiDaniele Bottai
Daniele Bottai
EFElisabetta Di Fede
Elisabetta Di Fede
VALENTINA MASsAVALENTINA MASsA
VALENTINA MASsA
Cornelia de Lange Syndrome (CdLS) is a rare developmental disorder affecting a multitude of organs including the central nervous system, inducing a variable neurodevelopmental delay. CdLS malformations derive from the deregulation of developmental pathways, inclusive of the canonical WNT pathway. We have evaluated MRI anomalies and behavioral and neurological clinical manifestations in CdLS patients. Importantly, we observed in our cohort a significant association between behavioral disturbance and structural abnormalities in brain structures of hindbrain embryonic origin. Considering the cumulative evidence on the cohesin-WNT-hindbrain shaping cascade, we have explored possible ameliorative effects of chemical activation of the canonical WNT pathway with lithium chloride in different models: (I) Drosophila melanogaster CdLS model showing a significant rescue of mushroom bodies morphology in the adult flies; (II) mouse neural stem cells restoring physiological levels in proliferation rate and differentiation capabilities toward the neuronal lineage; (III) lymphoblastoid cell lines from CdLS patients and healthy donors restoring cellular proliferation rate and inducing the expression of CyclinD1. This work supports a role for WNT-pathway regulation of CdLS brain and behavioral abnormalities and a consistent phenotype rescue by lithium in experimental models.